Stoke Therapeutics, Inc.
Price Action
Technical Summary
EMERGING TRENDStoke Therapeutics, Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is weak (RS Rating: 44), showing significant lag compared to the market leaders. Earnings contraction of 142% provides fundamental context to the price action. Investors should exercise caution due to high volatility (65% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $30.44 | +7.47% | ABOVE |
| 50 SMA | $31.43 | +4.09% | ABOVE |
| 100 SMA | $32.79 | -0.26% | BELOW |
| 150 SMA | $32.33 | +1.17% | ABOVE |
| 200 SMA | $31.13 | +5.07% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is STOK in an uptrend right now?
STOK has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is STOK overbought or oversold?
STOK's RSI (14) is 61. The stock is in neutral territory, neither overbought nor oversold.
Is STOK outperforming the market?
STOK has a Relative Strength (RS) Rating of 44 out of 99. STOK is currently lagging the broader market.
Where is STOK in its 52-week range?
STOK is trading at $32.71, which is 81% of its 52-week high ($40.22) and 74% above its 52-week low ($11.66).
How volatile is STOK?
STOK has a Beta of 0.77 and 52-week volatility of 65%. It's less volatile than the S&P 500 - generally more stable.